Counterfeit Medicine in India: Are We Heading in the Right Direction at the Desired Pace?

Counterfeit medicines pose a significant global health threat, with developing countries like India particularly vulnerable. This article examines India's efforts to combat pharmaceutical counterfeiting, evaluating the regulatory framework, technological interventions, and enforcement mechanisms against global best practices. While India has made notable strides through legislative reforms and technological innovations, challenges persist in implementation, coordination, and resource allocation. The paper provides a comparative analysis with successful anti-counterfeiting strategies from countries such as the United States, European Union, China, and Nigeria, highlighting lessons India can adopt. The research concludes that while India is moving in the right direction, the pace of progress remains insufficient to address the scale and complexity of the problem. Recommendations include strengthening regulatory capacity, enhancing stakeholder collaboration, investing in advanced detection technologies, improving public awareness campaigns, and accelerating the adoption of global best practices in pharmaceutical authentication and supply chain security.